MBM PHARMA
ActiveActs, filings and financial milestones
Deadline for the 2026 accounts:
2026
26-06
abbreviated format · 35 days before the deadline
13-03
Gazette deed
Registered office moved within AuderghemNew seat: Avenue Tedesco 7-1160 Auderghem · Previous seat: Avenue Tedesco 26 à 1160 Auderghem · Power of attorney5 points ▸
Gazette deed
Registered office moved within Auderghem
New seat: Avenue Tedesco 7-1160 Auderghem · Previous seat: Avenue Tedesco 26 à 1160 Auderghem · Power of attorney5 points ▸
- General meeting, 22-12-2025
- Registered-office move, Avenue Tedesco 7-1160 Auderghem
- Power of attorney, Thierry Graulich
- Power of attorney, Christophe Dereume
- Power of attorney, Isabelle De Roose
2025
31-12
Financial
Highest result from 2018 to 2025net €354,875 ▲27.9%
The operating result of €433,732 and the net result of €354,875 are both a record.
01-07
full format · 30 days before the deadline
2024
04-11
Gazette deed
Appointment: VV Finance (director)Permanent representative: Jean-Philippe WYDOCK4 points ▸
Gazette deed
Appointment: VV Finance (director)
Permanent representative: Jean-Philippe WYDOCK4 points ▸
- General meeting, 13-03-2024
- Director appointment, VV Finance (director)
- Permanent representative, Jean-Philippe WYDOCK
- Board meeting, “Conseil d'Administration” (deed in French)
21-06
full format · 40 days before the deadline
2023
29-06
full format · 32 days before the deadline
2022
31-12
Financial
Equity above €200,000equity €294,208 ▲84.7%
With a profit in every financial year since 2018, equity grows to €294,208.
20-04
Gazette deed
Merger: MBM PHARMA takes over FISCALEX CONSULTResignations: MBM Groupe (director) and GRAULICH Thierry (director) · Reappointments: MBM Groupe (director) and GRAULICH Thierry (director) · Permanent representative: DEREUME Christophe22 points ▸
Gazette deed
Merger: MBM PHARMA takes over FISCALEX CONSULT
Resignations: MBM Groupe (director) and GRAULICH Thierry (director) · Reappointments: MBM Groupe (director) and GRAULICH Thierry (director) · Permanent representative: DEREUME Christophe22 points ▸
- General meeting, 31-03-2022
- Other provision, “dispense de rapports de fusion, PREMIERE RESOLUTION” (deed in French)
- Other provision, “dispense de lecture et formalités préalables, DEUXIEME RESOLUTION” (deed in French)
- Other provision, “connaissance et discussion des rapports d'apport en nature, TROISIEME RESOLUTION” (deed in French)
- Auditor report, “pièces non remises au moins un mois avant l'acte, rapport non transmis 15 jours avant l'acte de fusion, sans impact significatif sur le contrôle, apports en nat…” (deed in French)
- Merger, “approuve le projet de fusion et l'absorption”, 155457.04 (deed in French)
- Other provision, “passent de plein droit et sans formalité, à acquitter en lieu et place avec intérêts et remboursements aux échéances convenues, constat de transfert et conditio…” (deed in French)
- Director resignation, MBM Groupe (director)
- Director resignation, GRAULICH Thierry (director)
- Director reappointment, MBM Groupe (director (not named in the articles))
- Director reappointment, GRAULICH Thierry (director (not named in the articles))
- Permanent representative, DEREUME Christophe
- The act holds 10 more points.
18-03
full format · 135 days before the deadline
23-02
Gazette deed
Merger proposal: MBM PHARMA takes over FISCALEX CONSULTAccounting effect7 points ▸
Gazette deed
Merger proposal: MBM PHARMA takes over FISCALEX CONSULT
Accounting effect7 points ▸
- General meeting, 14-02-2022
- Merger, “registre des actionnaires de la société, fusion par absorption” (deed in French)
- Accounting effect, 01-01-2022
- Other provision, “droits spéciaux et titres autres que les parts” (deed in French)
- Other provision, “rapports articles 12:25 et 12:26 et émoluments article 12:26, tous les actionnaires et titulaires de droits de vote de chacune des deux sociétés” (deed in French)
- Other provision, “avantages particuliers aux membres des organes de gestion des sociétés appelées à fusionner” (deed in French)
- Other provision, “justification de la fusion” (deed in French)
2021
31-12
Financial
Equity above €150,000equity €159,317 ▲8.1%
With a profit in every financial year since 2018, equity grows to €159,317.
Show earlier events
02-07
full format · 29 days before the deadline
2020
31-12
Financial
Weakest financial yearnet €143,944 ▼42.4%
The net result drops to €143,944, the lowest from 2018 to 2025. It recovers the following year.
09-07
full format · 22 days before the deadline
2019
31-12
Financial
Equity above €100,000equity €103,389 ▲109%
With a profit in every financial year since 2018, equity grows to €103,389.
21-06
full format · 40 days before the deadline
2018
21-08
full format · 21 days late
2017
23-06
full format · 38 days before the deadline
1995
03-01
Gazette deed
Incorporation
Financial milestoneGazette deedNBB filingFinancial milestones sit on the financial year-end date, not the filing date.
Sources:Publications in the Belgian Official GazetteFilings with the National Bank